6872 — TenNor Therapeutics (Suzhou) Balance Sheet
0.000.00%
Last trade - 00:00- HK$5.32bn
- HK$4.56bn
Annual balance sheet for TenNor Therapeutics (Suzhou), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 58.1 | 97.8 | 184 |
| Net Total Receivables | 2.31 | 2.77 | 0.007 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 63.6 | 102 | 191 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 4.26 | 1.57 | 2.87 |
| Net Intangible Assets | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 96.1 | 133 | 227 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 831 | 65.6 | 38.1 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 855 | 1,031 | 73.2 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| Total Equity | -759 | -898 | 154 |
| Total Liabilities & Shareholders' Equity | 96.1 | 133 | 227 |
| Total Common Shares Outstanding |